Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial.

Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial.

Show other versions (1)

<h4>Introduction</h4>This trial evaluates whether daily low-dose aspirin initiated before 16 weeks of gestation can reduce preeclampsia and fetal growth restriction in nulliparous women identified by first-trimester uterine artery Dopplers as at high risk of preeclampsia.<h4>Method...

Full description

Bibliographic Details
Main Authors: Caroline Diguisto, Amelie Le Gouge, Marie-Sara Marchand, Pascal Megier, Yves Ville, Georges Haddad, Norbert Winer, Chloé Arthuis, Muriel Doret, Veronique Houfflin Debarge, Anaig Flandrin, Hélène Laurichesse Delmas, Denis Gallot, Pierre Mares, Christophe Vayssiere, Loïc Sentilhes, Marie-Therese Cheve, Anne Paumier, Luc Durin, Bruno Schaub, Veronique Equy, Bruno Giraudeau, Franck Perrotin, Groupe de Recherche en Obstétrique et Gynécologie (GROG)
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0275129

Internet

https://doi.org/10.1371/journal.pone.0275129

Similar Items